FDA Inspection 1026145 — Daniel Hsia
The FDA completed an inspection of Daniel Hsia on August 23, 2017 in Baton Rouge, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 23, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Baton Rouge, LA (United States)
Additional Details
Sponsor, Contract Research Organization